Jonathan Tobin speaks to Vox Markets about Artios and its new ATR inhibitor programme

Vox Markets Daily

7th November 2019

Jonathan Tobin, Investment Director, speaks to Vox Markets about our portfolio companies Artios Pharma which has announced the expansion of its DNA Damage Response pipeline with a new asset.